A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-Term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial.
about
A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-Term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A Randomized Controlled Study ...... lities: Linagliptin-LTC Trial.
@en
A Randomized Controlled Study Comparing a DPP4 Inhibitor
@nl
type
label
A Randomized Controlled Study ...... lities: Linagliptin-LTC Trial.
@en
A Randomized Controlled Study Comparing a DPP4 Inhibitor
@nl
prefLabel
A Randomized Controlled Study ...... lities: Linagliptin-LTC Trial.
@en
A Randomized Controlled Study Comparing a DPP4 Inhibitor
@nl
P2093
P2860
P1476
A Randomized Controlled Study ...... lities: Linagliptin-LTC Trial.
@en
P2093
Darin E Olson
David Chachkhiani
Francisco J Pasquel
Guillermo E Umpierrez
Heqiong Wang
J Sonya Haw
Maya Fayfman
Priyathama Vellanki
Sahebi Saiyed
Saumeth Cardona
P2860
P356
10.1016/J.JAMDA.2017.11.002
P577
2017-12-27T00:00:00Z